Yes. Injectable NAD+ is a compounded prescription preparation dispensed pursuant to a valid prescription from a licensed healthcare provider. A telehealth consultation and intake review are required before dispensing to ensure the formulation and dosing protocol are appropriate for your health history and goals.

Injectable NAD+ is generally well tolerated. Some patients experience mild and transient effects during or after administration, including flushing, a sensation of warmth, lightheadedness, nausea, or mild headache — these are more common with IV infusion at faster rates and typically resolve quickly. Injection site reactions may occur with subcutaneous administration. Report any unusual or persistent symptoms to your provider.

NAD+ is not appropriate for patients who are pregnant or breastfeeding, as safety data in these populations is insufficient. Patients with active malignancy or a personal history of cancer should consult both their provider and treating oncologist before initiating therapy, as NAD+'s central role in cellular energy metabolism may theoretically influence cellular proliferation. Those with significant cardiovascular conditions or severe hepatic or renal impairment require individualized provider review before starting. This preparation is intended for adult patients only.

Formal drug interaction studies for injectable NAD+ have not been conducted. NAD+ participates centrally in sirtuin activity — proteins that regulate gene expression, DNA repair, and inflammation. Patients on medications influencing these pathways, including niacin derivatives, certain chemotherapy agents, or PARP inhibitors, should discuss concomitant use with their provider before beginning. Always provide a complete medication list before starting treatment.

Patients with a history of any malignancy should discuss NAD+ therapy with their treating oncologist and prescribing provider before initiating treatment. Those with metabolic syndrome, cardiovascular disease, or significant renal or hepatic impairment require individualized review. Your provider requires a complete medical history before prescribing and will determine whether NAD+ is appropriate given your individual health profile.